Daiwa Securities Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67K | Buy |
2,348
+132
| +6% | +$3.77K | ﹤0.01% | 1028 |
|
|
2025
Q1 | $65K | Sell |
2,216
-66
| -3% | -$1.94K | ﹤0.01% | 995 |
|
|
2024
Q4 | $66K | Buy |
2,282
+175
| +8% | +$5.06K | ﹤0.01% | 1032 |
|
|
2024
Q3 | $97K | Buy |
2,107
+15
| +0.7% | +$691 | ﹤0.01% | 1014 |
|
|
2024
Q2 | $85K | Sell |
2,092
-7,889
| -79% | -$321K | ﹤0.01% | 1035 |
|
|
2024
Q1 | $255K | Sell |
9,981
-556
| -5% | -$14.2K | ﹤0.01% | 947 |
|
|
2023
Q4 | $95K | Buy |
10,537
+3,182
| +43% | +$28.7K | ﹤0.01% | 1015 |
|
|
2023
Q3 | $47K | Hold |
7,355
| – | – | ﹤0.01% | 1062 |
|
|
2023
Q2 | $82K | Buy |
7,355
+272
| +4% | +$3.03K | ﹤0.01% | 1035 |
|
|
2023
Q1 | $109K | Buy |
7,083
+1,348
| +24% | +$20.7K | ﹤0.01% | 980 |
|
|
2022
Q4 | $127K | Buy |
5,735
+955
| +20% | +$21.1K | ﹤0.01% | 969 |
|
|
2022
Q3 | $78K | Buy |
4,780
+4,624
| +2,964% | +$75.5K | ﹤0.01% | 1022 |
|
|
2022
Q2 | $2K | Hold |
156
| – | – | ﹤0.01% | 1240 |
|
|
2022
Q1 | $3K | Hold |
156
| – | – | ﹤0.01% | 1220 |
|
|
2021
Q4 | $4K | Hold |
156
| – | – | ﹤0.01% | 1219 |
|
|
2021
Q3 | $4K | Buy |
156
+85
| +120% | +$2.18K | ﹤0.01% | 1194 |
|
|
2021
Q2 | $2K | Hold |
71
| – | – | ﹤0.01% | 1148 |
|
|
2021
Q1 | $2K | Hold |
71
| – | – | ﹤0.01% | 1157 |
|
|
2020
Q4 | $2K | Buy |
+71
| New | +$2K | ﹤0.01% | 1132 |
|